Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Cdymax (India) Pharma Private Limited
483
•Cdymax (India) Pharma Private Limited•April 25, 2025

Cdymax (India) Pharma Private Limited – FDA 483, Apr 25, 2025

Record Details

Cydmax (India) Pharma Private Limited, an API manufacturer in Jigani, Bangalore, received a Form 483 with significant observations related to quality control, laboratory practices, and manufacturing controls. The inspection revealed critical issues including inadequate investigations into out-of-specification results, unvalidated test methods, deficient quality unit oversight, and poor contamination control during API manufacturing and equipment cleaning. These findings indicate a systemic lack of adherence to cGMP regulations, posing a risk to product quality and patient safety.

Company
Cdymax (India) Pharma Private Limited
Inspection date
April 25, 2025
Product type
drugs
Office
Office of Inspections and Investigations
People
  • Arwaa Kampetya
  • Arsen Karapetyan
  • Arsen Karpetvan
View Company Profile

ID · 6a4e0715-7b86-4b4f-9b03-429b9b408bdd

Violation Codes1
21 CFR 211.192

Full citation text and observation details available on the Dashboard.

Other documents for Cdymax (India) Pharma Private Limited
  • WARNING_LETTER - 2025-04-25April 25, 2025
  • 483 - 2019-05-17May 17, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Cdymax (India) Pharma Private Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.